Primary CNS lymphoma: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
==Background==
==Background==
*AIDS defining malignancy that is strongly related to Epstein-Barr virus (EBV) infection
*AIDS defining malignancy that is strongly related to [[Epstein-Barr virus]] (EBV) infection
*Occurs with profound immunosuppression (CD4 counts <50cells/uL)
*Occurs with profound immunosuppression (CD4 counts <50cells/uL)
* Accounts for approximately 20 to 30% of CNS lesions in patients with AIDs
* Accounts for approximately 20 to 30% of CNS lesions in patients with AIDs
Line 13: Line 13:
*CT scan: well-defined focal lesion, isodense or hyperdense to the gray matter
*CT scan: well-defined focal lesion, isodense or hyperdense to the gray matter
*MRI scan (higher diagnostic yield): variable, isointense or hypointense lesions on T1-weighted images
*MRI scan (higher diagnostic yield): variable, isointense or hypointense lesions on T1-weighted images
**Lesions that involve the corpus callosum, periventricular, or periependymal areas are more likely to be due to a lymphoma
**Lesions that involve the corpus callosum, periventricular, or periependymal areas are more likely to be due to a lymphoma<ref>Forsyth PA. Biology and management of AIDS-associated primary CNS lymphomas. Hematol Oncol Clin North Am. 1996;10(5):1125-34.</ref>
**Solitary lesions are often large (>4cm)<ref>Thurnher MM. CNS involvement in AIDS: spectrum of CT and MR findings. Eur Radiol. 1997;7(7):1091-7.</ref>
*Lumbar puncture:  
*Lumbar puncture:  
**CSF cytology
**CSF cytology
**CSF EBV PCR
**CSF EBV PCR
**Should also obtain toxoplasma serologies, most are treated empirically for toxoplasma while serology is pending
**Should also obtain [[toxoplasma]] serologies, most are treated empirically for toxoplasma while serology is pending
*Stereotactic brain biopsy if necessary
*Stereotactic brain biopsy if necessary



Revision as of 05:52, 5 May 2017

Background

  • AIDS defining malignancy that is strongly related to Epstein-Barr virus (EBV) infection
  • Occurs with profound immunosuppression (CD4 counts <50cells/uL)
  • Accounts for approximately 20 to 30% of CNS lesions in patients with AIDs

Clinical Features

  • Can present with a variety of focal or nonfocal signs and symptoms
  • Confusion, lethargy, memory loss, hemiparesis, aphasia, mental status changes, seizures
  • Constitutional symptoms (systemic B symptoms)

Differential Diagnosis

Evaluation

  • CT scan: well-defined focal lesion, isodense or hyperdense to the gray matter
  • MRI scan (higher diagnostic yield): variable, isointense or hypointense lesions on T1-weighted images
    • Lesions that involve the corpus callosum, periventricular, or periependymal areas are more likely to be due to a lymphoma[1]
    • Solitary lesions are often large (>4cm)[2]
  • Lumbar puncture:
    • CSF cytology
    • CSF EBV PCR
    • Should also obtain toxoplasma serologies, most are treated empirically for toxoplasma while serology is pending
  • Stereotactic brain biopsy if necessary

Management

  • High-dose methotrexate therapy (3 g/m2 for four to eight cycles)
  • Steroids
  • Potent antiretroviral therapy
  • Radiation therapy

Disposition

See Also

HIV - AIDS (main)

External Links

References

  1. Forsyth PA. Biology and management of AIDS-associated primary CNS lymphomas. Hematol Oncol Clin North Am. 1996;10(5):1125-34.
  2. Thurnher MM. CNS involvement in AIDS: spectrum of CT and MR findings. Eur Radiol. 1997;7(7):1091-7.